I lead data-driven transformations in regulated pharma and industrial manufacturing by stabilizing operations, redesigning end-to-end systems, and embedding governance and capability that sustain performance over time. The cases below show how results follow when flow, decision ownership, and organizational design are fixed first — with digital solutions applied deliberately, not by default.

Release Lead Time Reduction in Regulated Pharma Operations, Reduced end-to-end batch release lead time by 35% by redesigning flow, ownership, and stage-based governance—without compromising compliance. -> Read the case

Deviation Lead Time Reduction in Regulated Pharma Operations, Cut overdue deviations from ~95% to ~20% by eliminating rework loops and aligning decision quality across QA and Production. -> Read the case

Instant Release Robotic Process Automation (RPA) — Automation After Re-engineering, -> Read the case

Post-Merger Integration & Technology Transfer, Stabilized operations and executed production and technology transfer under post-merger uncertainty while protecting delivery, quality, and cost. -> Read the case

ERP-Enabled Organizational Transformation (Aliprop), Redesigned the operating model around product ownership and enabled it with a tailor-made ERP to eliminate duplication and restore end-to-end accountability. -> Read the case

Lean Six Sigma Deployment & Capability Building, -> Read the case

OEM-Driven Growth & Operating Model Transformation, Enabled OEM-driven growth through operating model redesign, productivity discipline, and ERP enablement—delivering a 30% increase in net profit per FTE. -> Read the case

Bayer – Multi-Site Production System Roll-out -> Read the case